In cooperation with seven academic societies related to infectious diseases (The Joint Review Committee of Seven Academic Societies for the Promotion of Infectious Disease Therapy and Drug Discovery and Japanese Association of Medical Technologists), AMR Alliance Japan (Secretariat: Health and Global Policy Institute) has conducted a survey on the awareness of drug development and testing within AMR countermeasures among members of the aforementioned societies, including physicians, pharmacists, and Medical Technologists. Overall results of this study are available below.

*Free-form responses and detailed reports will be published later.

[Survey Overview]

• Objectives: To clarify the gap between the awareness of the issue in the field and the related policy by identifying the attitudes of medical professionals (physicians, pharmacists and medical technologists) engaged in infectious disease care toward the Drug Development and Testing system.
• Research period: November 1, 2022 – November 14, 2022
• Subjects: Physicians/ Pharmacists/ Medical Technologists of eligible society officers and members
• Method: Email and website posting
• Number of responses: 391 (Physicians 72, Pharmacists 72, Medical Technologists 247)